胶质瘤
趋化因子受体
CXCR4型
癌症研究
生物
转移
CXCR4拮抗剂
细胞迁移
受体
癌症
趋化因子
细胞
遗传学
生物化学
作者
Yuxiang Dai,Yu Chen,Lu Zhang,Longyang Cheng,Hongbin Ni,Wei Liang
标识
DOI:10.1016/j.brainres.2023.148647
摘要
Glioma is the most common primary brain tumor. It is prone to progress and have high rate of mortality regardless of radiation or chemotherapy due to its invasive growth features. Chemokine and its receptor CXCL12 and CXCR4 play important roles in cancer metastasis. In this study, we investigate the role of CXCR4 in the progression of glioma by various molecular technologies, including qRT-PCR, Western blotting, wound closure assay, transwell assay et al. It was found that CXCR4 was overexpressed in glioma tissues. The expression of CXCR4 was correlated with patients’ overall survival. Wound closure assay and transwell invasion assay showed that inhibition of CXCR4 significantly reduced the expression of biomarkers related to the formation of invadopodium, leading to decrease the invasion and migration of glioma tumor cells. Knocking down the nuclear receptor Nur77 remarkably decreased CXCR4 expression and reduced glioma cell invasion and migration. The reduction of glioma cell invasion and migration were observed after Nur77 inhibitor treatment. Taken together, these results indicated that CXCR4 is critical in promoting glioma migration and invasion. Inhibition of Nur77 reduces CXCR4 related cancer progression.
科研通智能强力驱动
Strongly Powered by AbleSci AI